Version 2 2023-11-27, 12:17Version 2 2023-11-27, 12:17
Version 1 2023-02-21, 14:42Version 1 2023-02-21, 14:42
journal contribution
posted on 2023-11-27, 12:17authored byLuisa Herrmann, Petya Vicheva, Vanessa Kasties, Lena V. Danyeli, Gregor R. Szycik, Dominik DenzelDominik Denzel, Yan Fan, Johan Van der Meer, Johannes C. Vester, Herbert Eskoetter, Myron SchultzMyron Schultz, Martin Walter
This is a plain language summary of a published peer-reviewed article. It refers to a clinical trial demonstrating effects of the natural medication Neurexan in reducing hyperactivity in a brain region responsible for emotional processing.
This summary was not peer-reviewed but it represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please read the full open-access article online.